TIAA CREF Investment Management LLC boosted its position in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 6.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 146,547 shares of the specialty chemicals company’s stock after buying an additional 8,272 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.76% of Innophos Holdings worth $7,909,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of IPHS. Great West Life Assurance Co. Can boosted its stake in shares of Innophos Holdings by 5.7% in the first quarter. Great West Life Assurance Co. Can now owns 26,926 shares of the specialty chemicals company’s stock worth $1,452,000 after buying an additional 1,447 shares during the last quarter. Personal Capital Advisors Corp boosted its stake in shares of Innophos Holdings by 9.6% in the first quarter. Personal Capital Advisors Corp now owns 110,646 shares of the specialty chemicals company’s stock worth $5,939,000 after buying an additional 9,717 shares during the last quarter. State of Alaska Department of Revenue raised its position in shares of Innophos Holdings by 81.4% in the first quarter. State of Alaska Department of Revenue now owns 3,810 shares of the specialty chemicals company’s stock worth $205,000 after buying an additional 1,710 shares during the period. Louisiana State Employees Retirement System raised its position in shares of Innophos Holdings by 1.3% in the first quarter. Louisiana State Employees Retirement System now owns 7,900 shares of the specialty chemicals company’s stock worth $426,000 after buying an additional 100 shares during the period. Finally, Americafirst Capital Management LLC bought a new position in shares of Innophos Holdings during the first quarter worth approximately $528,000. 94.32% of the stock is currently owned by institutional investors.

Shares of Innophos Holdings, Inc. (NASDAQ IPHS) traded down 0.98% on Friday, reaching $47.38. 144,272 shares of the company were exchanged. The company’s 50 day moving average is $43.53 and its 200 day moving average is $47.20. Innophos Holdings, Inc. has a 12-month low of $37.02 and a 12-month high of $58.22. The firm has a market capitalization of $918.98 million, a PE ratio of 20.69 and a beta of 0.85.

Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.52 by $0.05. The business had revenue of $179.14 million for the quarter, compared to analyst estimates of $172.65 million. Innophos Holdings had a net margin of 6.46% and a return on equity of 13.79%. The company’s revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.63 earnings per share. Analysts forecast that Innophos Holdings, Inc. will post $2.51 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 6th. Shareholders of record on Friday, August 18th will be given a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 4.05%. The ex-dividend date is Wednesday, August 16th. Innophos Holdings’s dividend payout ratio is 84.21%.

TRADEMARK VIOLATION WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/08/04/innophos-holdings-inc-iphs-stake-increased-by-tiaa-cref-investment-management-llc-updated-updated-updated.html.

A number of brokerages recently commented on IPHS. BidaskClub lowered shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Zacks Investment Research upgraded shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Finally, Sidoti upgraded shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a research note on Friday, May 26th. They noted that the move was a valuation call.

About Innophos Holdings

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Institutional Ownership by Quarter for Innophos Holdings (NASDAQ:IPHS)

Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.